LeaderShares AlphaFactor Tactical Focused ETF Vs. Rapt Therapeutics, Inc. Industry Stock Comparison

Buy

60

LSAT
LeaderShares AlphaFactor Tactical Focused ETF

Last Price:

$39.20

Seasonality Move:

3.88%

Sell

40

RAPT
Rapt Therapeutics, Inc.

Last Price:

$33.91

Seasonality Move:

-27.57%

Buy

60

LeaderShares AlphaFactor Tactical Focused ETF (LSAT) is a Buy

Is LeaderShares AlphaFactor Tactical Focused ETF a Buy, Sell or Hold?

The current LeaderShares AlphaFactor Tactical Focused ETF [LSAT] share price is $38.86. The Score for LSAT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
LSAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

40

Rapt Therapeutics, Inc. (RAPT) is a Sell

Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?

The current Rapt Therapeutics, Inc. [RAPT] share price is $33.87. The Score for RAPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LSAT Stock Price Chart

What is LeaderShares AlphaFactor Tactical Focused ETF's stock price today?

The LeaderShares AlphaFactor Tactical Focused ETF share price today is $38.86

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LSAT is experiencing selling pressure, which indicates risk of future bearish movement.

RAPT Stock Price Chart

What is Rapt Therapeutics, Inc.'s stock price today?

The Rapt Therapeutics, Inc. share price today is $33.87

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.

LSAT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.24	Sell
Relative Strength Index (14 RSI):	32.79	Sell
Chaikin Money Flow:	-4561	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(39.36 - 40.32)	Sell
Bollinger Bands (100):	(39.74 - 41.46)	Sell

RAPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	9.53	Buy
Relative Strength Index (14 RSI):	51.15	Buy
Chaikin Money Flow:	79100	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(32.58 - 35.84)	Sell
Bollinger Bands (100):	(16.83 - 33.91)	Buy

LSAT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	39.3	Sell
20-day SMA:	39.8	Sell
50-day SMA:	39.96	Sell
200-day SMA:	39.99	Sell
8-day EMA:	39.32	Sell
20-day EMA:	39.63	Sell
50-day EMA:	39.41	Sell
200-day EMA:	26.54	Buy

RAPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	35	Sell
20-day SMA:	34.72	Sell
50-day SMA:	31.71	Buy
200-day SMA:	17.02	Buy
8-day EMA:	31.84	Buy
20-day EMA:	21.97	Buy
50-day EMA:	11.45	Buy
200-day EMA:	3.3	Buy

LeaderShares AlphaFactor Tactical Focused ETF Earnings Growth & LSAT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.

LeaderShares AlphaFactor Tactical Focused ETF Technical Analysis

	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31
	Dec
	16	17	18	19	22	24	26	29	30	31
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rapt Therapeutics, Inc. Technical Analysis

	Dec 17	Dec 18	Dec 19	Dec 22	Dec 23	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31
	Dec
	17	18	19	22	23	24	26	29	30	31
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):